Delian Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Delian Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 26, 2026	Neowise	$28.7M Series B	—	GEM, Sun Yuandong
Aug 2, 2023	Hunan Tree Industrial Manufacturing	$13.9M Series A	Delian Capital, Shunxi Fund	—
Sep 12, 2022	Redbud Medicine	$10.0M Series A	Delian Capital, Hongfeng Capital	—
Mar 1, 2020	Amunix	$73.0M Series A	Otello Stampacchia	Frazier Healthcare Partners, Casdin Capital, David Hirsch, Polaris Partners, Redmile Group, Two River, Venrock
Dec 5, 2019	Hummingbird Bioscience	$19.0M Series B	G.N. Tech Venture Capital, Mirae Asset Venture Investment	DAValue-GiltEdge, HB Investment, Heritas Capital, Kiwoom Investment-Shinhan Capital, Mirae Asset Capital, SEEDS Capital, Wooshin Venture Investment
Aug 28, 2019	HiFiBiO	$67.0M Series C	IDG Capital	Hanne Capital, Hongshan Capital Group (Sequoia Capital China), Kite, LYFE Capital, VI Ventures
May 3, 2018	OnKure Therapeutics	$7.0M Series A	Zhao Guobao	—
Apr 27, 2018	EcoFlow	$4.0M Series A	—	Chunjia Assets, ESID, Guangzhou Penghui Energy, SCUD Group
Dec 6, 2017	MicuRx Pharmaceuticals	$890K Other Equity	BVCF Management, Delian Capital	—
Sep 26, 2016	MicuRx Pharmaceuticals	$55.0M Series C	GP Capital	3E Bioventures Capital, GP TMT Capital